Enhanced mitochondrial radical production in patients with rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma

Free Radical Research

Volumn 25, Issue 2, 1996, Pages 161-169

  Miesel, Ralf ^a,b   Murphy, Michael P ^a   Kröger, Hans ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b German Rheumatology Research Center   (Germany)

Author keywords

Lucigenin chemiluminescence; Mitochondrial oxidative stress; Reactive oxygen species; Respiratory chain inhibitors; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

FREE RADICAL; LUCIGENIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DAMAGE; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MITOCHONDRIAL RESPIRATION; MONOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

EID: 0029956657     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769609149921     Document Type: Article

References (31)

1. B. Beutler and A. Cerami (1989) The biology of cachectin/TNF: a primary mediator of the host response. Annual Review of Immunology, 7, 625-655.
2. W. Fiers (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Letters, 285, 199-212.
3. B. Beutler (1992) Tumor necrosis factors: The molecules and their emerging role in medicine. Raven Press, New York.
4. C. Tetta, G. Camussi, V. Modena, C. Di Vittorio and C. Baglioni (1990) Tumor necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Annals of Rheumatic Disease, 49, 665-667.
5. L. Aloe, L. Probert, G. Kollias, L. Bracci-Laudieri, M.G. Spillantini and R. Levi-Montalcini (1993) The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors, 9, 149-155; 1993.
6. R. Miesel, R. Hartung, M. Zuber and H. Kröger (1995) Total radical-trapping antioxidative capacity of plasma and whole blood chemiluminescence in patients with inflammatory and autoimmune rheumatic diseases. Redox Report, 1, 323-330.
7. R. Miesel, H. Kröger, N. Ulbrich, M. Kurpisz, A. Dietrich, M. Ohde and B. Brandl (1994) Modulation of arthritis by suppression of proinflammatory responses of phagocytes by an active center analogue of superoxide dismutase. Zeitschrift Rheumatology, 53, 21.
8. R. Miesel, R. Hartung and H. Kröger (1996) Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases. Inflammation, in press.
9. T. Hennet, C. Richter and E. Peterhans (1993) Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochemical Journal, 289, 587-592.
10. H. Nohl and W. Jordan (1986) The mitochondrial site of superoxide formation. Biochemical and Biophysical Research Communications, 138, 533-539.
11. M.K. Shigenaga, T.M. Hagen and B.N. Ames (1994) Oxidative damage and mitochondrial decay in aging. Proceedings of the National Academy of Sciences USA, 91, 10771-10778.
12. P. Lestienne and N. Bataillé (1994) Mitochondrial DNA alterations and genetic diseases: a review. Biomedicine and Pharmacotherapy, 48, 199-214.
13. H.J. Tritschler, L. Packer and R.M. Medori (1994) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochemistry and Molecular Biology International, 34, 169-181.
14. K. Schulze-Osthoff, A.C. Bakkers, B. Vanhasebroeck, R. Beyaert, W.A. Jacobs and W. Fiers (1992) Cytotoxic activity of tumor necrosis factor is mediated by damage to mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. Journal of Biological Chemistry, 267, 5317-5323.
15. P. Reynier, J.F. Pellisier, J.R. Harle and Y. Malthiéry (1994) Multiple deletions of mitochondrial DNA in polymyalgia rheumatica. Biochemical and Biophysical Research Communications, 205, 375-380.
16. R.L. Esterline and M.A. Trush (1989) Lucigenin chemiluminescence and its relationship to mitochondrial respiration in phagocytic cells. Biochemical and Biophysical Research Communications, 159, 584-591.
17. S.J. Rembish and M.A. Trush (1994) Further evidence that lucigenin-derived chemiluminescence monitors mitochondrial superoxide generation in rat alveolar macrophages. Free Radical Biology and Medicine, 17, 117-126.
18. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, T.A. Medsger Jr., D.M. Mitchell, D.H. Neustadt, R.S. Pinals, J.G. Schaller, J.T. Sharp, R.L. Wilder and G.G. Hunder (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 31, 315-324.
19. C. Yea, A.R. Cross and O.T. Jones (1990) Purification and some properties of the 45 kDa diphenylene iodonium-binding flavoprotein of neutrophil NADPH oxidase. Biochemical Journal, 265, 95-100.
20. R.C. Allen (1986) Phagocyte leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. In Methods in Enzymology (eds. M.A. Luca and W.D. McElroy), Academic Press, New York, vol. 133, pp. 449-493.
21. A.L. Blair, I.A. Cree, J.S. Becks and J.G.M. Hastings (1991) Measurement of phagocyte chemiluminescence in microtitre plate formate. Journal of Immunological Methods, 112, 163-168.
22. R. Miesel, N. Ulbrich, H. Kröger and A. Mitchison (1995) Assessment of collagen type II induced arthritis in mice by whole blood chemiluminescence. Autoimmunity, 19, 153-159.
23. R. Miesel and M. Zuber (1993) Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation, 17, 551-561.
24. M.J. Elliott, R.M. Maini, M. Feldmann, A. Long-Fox, P. Charles and F.M. Brenan (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF-α. Safety clinical efficacy and regulation of the acute phase response. British Journal of Rheumatology, 32, 209-216.
25. H. Kröger, R. Miesel, A. Dietrich, M. Ohde, E. Rajnavölgyi and H. Ockenfels (1996) Synergistic effects of thalidomide and poly(ADP-ribose) polymerase inhibition on collagen-induced arthritis in mice. Submitted.
26. H. Nohl and D. Hegner (1978) Do mitochondria produce oxygen radicals in vivo? European Journal of Biochemistry, 82, 563-567.
27. K. Schulze-Osthoff, R. Beyaert, V. Vandevorde, G. Hageman and W. Fiers (1993) Depletion of the mitochondrial electron transport chain abrogates the cytotoxic and gene-inductive effects of TNF. EMBO Journal, 12, 3095-3104.
28. T.E. Gunter, K.K. Gunter, S.S. Sheu and C.E. Gavine (1994) Mitochondrial calcium transport: physiological and pathological relevance. American Journal of Physiology, 267, 313-339.
29. R. Schreck, P. Rieber and P. Baeuerle (1992) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO Journal, 10, 2247-2258.
30. R. Schreck, K. Albermann and P.A. Baeuerle (1992) Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Research, 17, 221-237.
31. K. Arai, F. Lee and A. Miyajima (1990) Cytokines: coordinators of immune and inflammatory responses. Annual Review of Biochemistry, 59, 783-836.